In vitro- undersøgelser indikerede, at det enzym, der primært er ansvarlig for sitagliptins begrænsede metabolisering, er CYP3A4, med medvirken fra CYP2C8.
In vitro studies indicated that the primary enzyme responsible for the limited metabolism of sitagliptin was CYP3A4, with contribution from CYP2C8.